Carboplatin

"Carboplatin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An organoplatinum compound that possesses antineoplastic activity.

Descriptor ID	D016190
MeSH Number(s)	D02.691.800.338
Concept/Terms	Carboplatin Carboplatin cis-Diammine(cyclobutanedicarboxylato)platinum II CBDCA Blastocarb Blastocarb Carbosin Carbosin Carbotec Carbotec Ercar Ercar JM-8 JM-8 JM 8 JM8 Neocarbo Neocarbo NSC-241240 NSC-241240 NSC 241240 NSC241240 Paraplatin Paraplatin Paraplatine Platinwas Platinwas Ribocarbo Ribocarbo Carboplat Carboplat Nealorin Nealorin

Below are MeSH descriptors whose meaning is more general than "Carboplatin".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Organometallic Compounds [D02.691]
Organoplatinum Compounds [D02.691.800]
Carboplatin [D02.691.800.338]

Below are MeSH descriptors whose meaning is related to "Carboplatin".

Below are MeSH descriptors whose meaning is more specific than "Carboplatin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carboplatin" by people in this website by year, and whether "Carboplatin" was a major or minor topic of these publications.

Bar chart showing 43 publications over 22 distinct years, with a maximum of 5 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1997	0	1	1
1999	1	1	2
2000	1	1	2
2001	1	0	1
2002	1	0	1
2004	0	1	1
2005	0	1	1
2006	0	2	2
2007	1	0	1
2008	0	2	2
2009	0	2	2
2010	0	4	4
2011	1	2	3
2012	0	2	2
2014	0	2	2
2015	0	5	5
2016	1	1	2
2018	1	0	1
2019	1	1	2
2020	1	2	3
2022	0	2	2

Below are the most recent publications written about "Carboplatin" by people in Profiles.

Bowers RR, Andrade MF, Jones CM, White-Gilbertson S, Voelkel-Johnson C, Delaney JR. Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs). BMC Cancer. 2022 Apr 14; 22(1):410.

View in: PubMed
Safran HP, Winter K, Ilson DH, Wigle D, DiPetrillo T, Haddock MG, Hong TS, Leichman LP, Rajdev L, Resnick M, Kachnic LA, Seaward S, Mamon H, Diaz Pardo DA, Anderson CM, Shen X, Sharma AK, Katz AW, Salo J, Leonard KL, Moughan J, Crane CH. Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2022 02; 23(2):259-269.

View in: PubMed
Wang JL, Barth RF, Cavaliere R, Puduvalli VK, Giglio P, Lonser RR, Elder JB. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.

View in: PubMed
Sharma A, Babra DS, Joshi PV, Hall M, Gogbashian A, Vasdev N, Joseph M, Yazdan A, Kanfer E. Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers. In Vivo. 2020 Nov-Dec; 34(6):3675-3679.

View in: PubMed
Alifrangis C, Sharma A, Chowdhury S, Duncan S, Milic M, Gogbashian A, Agarwal S, Sahdev A, Wilson P, Harland S, Stoneham S, Lockley M, Rustin G, Oliver T, Berney D, Shamash J. Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients. Eur J Cancer. 2022 03; 164:105-113.

View in: PubMed
Owen DH, Williams TM, Bertino EM, Mo X, Webb A, Schweitzer C, Liu T, Roychowdhury S, Timmers CD, Otterson GA. Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer. Lung Cancer. 2019 08; 134:167-173.

View in: PubMed
Milic M, Hall M, Hawkins A, Gogbashian A, Rustin G, Sharma A. A Qualitative Analysis of the Impact of Carboplatin AUC 10 on Physical, Work Functioning and Bone Marrow Toxicity Among Seminoma Patients - A Single-centre Experience. In Vivo. 2019 Jan-Feb; 33(1):233-237.

View in: PubMed
Amini A, Eguchi M, Jones BL, Stokes WA, Gupta A, McDermott JD, Massarelli E, Bradley CJ, Karam SD. Comparing outcomes of concurrent chemotherapy regimens in patients 65 years old or older with locally advanced oropharyngeal carcinoma. Cancer. 2018 11 15; 124(22):4322-4331.

View in: PubMed
Noonan AM, Farren MR, Geyer SM, Huang Y, Tahiri S, Ahn D, Mikhail S, Ciombor KK, Pant S, Aparo S, Sexton J, Marshall JL, Mace TA, Wu CS, El-Rayes B, Timmers CD, Zwiebel J, Lesinski GB, Villalona-Calero MA, Bekaii-Saab TS. Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma. Mol Ther. 2016 Jun; 24(6):1150-1158.

View in: PubMed
Shields CL, Jorge R, Say EA, Magrath G, Alset A, Caywood E, Leahey AM, Jabbour P, Shields JA. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma. Asia Pac J Ophthalmol (Phila). 2016 Mar-Apr; 5(2):97-103.

View in: PubMed

People

Explore

Similar Concepts

Top Journals